List of Tables
Table 1. Global Cannabinoid Derived Pharmaceutical Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Cannabinoid Derived Pharmaceutical Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Cannabinoid Derived Pharmaceutical Market Competitive Situation by Manufacturers in 2024
Table 4. Global Cannabinoid Derived Pharmaceutical Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Cannabinoid Derived Pharmaceutical Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Cannabinoid Derived Pharmaceutical Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Cannabinoid Derived Pharmaceutical Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Cannabinoid Derived Pharmaceutical, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Cannabinoid Derived Pharmaceutical, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cannabinoid Derived Pharmaceutical, Product Type & Application
Table 12. Global Key Manufacturers of Cannabinoid Derived Pharmaceutical, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cannabinoid Derived Pharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabinoid Derived Pharmaceutical as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cannabinoid Derived Pharmaceutical Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Cannabinoid Derived Pharmaceutical Sales by Region (2020-2025) & (K Units)
Table 18. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Region (2020-2025)
Table 19. Global Cannabinoid Derived Pharmaceutical Sales by Region (2026-2031) & (K Units)
Table 20. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Region (2026-2031)
Table 21. Global Cannabinoid Derived Pharmaceutical Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Cannabinoid Derived Pharmaceutical Revenue Market Share by Region (2020-2025)
Table 23. Global Cannabinoid Derived Pharmaceutical Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Cannabinoid Derived Pharmaceutical Revenue Market Share by Region (2026-2031)
Table 25. North America Cannabinoid Derived Pharmaceutical Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Cannabinoid Derived Pharmaceutical Sales by Country (2020-2025) & (K Units)
Table 27. North America Cannabinoid Derived Pharmaceutical Sales by Country (2026-2031) & (K Units)
Table 28. North America Cannabinoid Derived Pharmaceutical Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Cannabinoid Derived Pharmaceutical Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Cannabinoid Derived Pharmaceutical Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Cannabinoid Derived Pharmaceutical Sales by Country (2020-2025) & (K Units)
Table 32. Europe Cannabinoid Derived Pharmaceutical Sales by Country (2026-2031) & (K Units)
Table 33. Europe Cannabinoid Derived Pharmaceutical Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Cannabinoid Derived Pharmaceutical Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Cannabinoid Derived Pharmaceutical Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Cannabinoid Derived Pharmaceutical Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Cannabinoid Derived Pharmaceutical Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Cannabinoid Derived Pharmaceutical Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Cannabinoid Derived Pharmaceutical Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cannabinoid Derived Pharmaceutical Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Cannabinoid Derived Pharmaceutical Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Cannabinoid Derived Pharmaceutical Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Cannabinoid Derived Pharmaceutical Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Cannabinoid Derived Pharmaceutical Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Cannabinoid Derived Pharmaceutical Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Cannabinoid Derived Pharmaceutical Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Cannabinoid Derived Pharmaceutical Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Cannabinoid Derived Pharmaceutical Sales (K Units) by Type (2020-2025)
Table 51. Global Cannabinoid Derived Pharmaceutical Sales (K Units) by Type (2026-2031)
Table 52. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Type (2020-2025)
Table 53. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Type (2026-2031)
Table 54. Global Cannabinoid Derived Pharmaceutical Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Cannabinoid Derived Pharmaceutical Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Cannabinoid Derived Pharmaceutical Revenue Market Share by Type (2020-2025)
Table 57. Global Cannabinoid Derived Pharmaceutical Revenue Market Share by Type (2026-2031)
Table 58. Global Cannabinoid Derived Pharmaceutical Price (US$/Unit) by Type (2020-2025)
Table 59. Global Cannabinoid Derived Pharmaceutical Price (US$/Unit) by Type (2026-2031)
Table 60. Global Cannabinoid Derived Pharmaceutical Sales (K Units) by Application (2020-2025)
Table 61. Global Cannabinoid Derived Pharmaceutical Sales (K Units) by Application (2026-2031)
Table 62. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Application (2020-2025)
Table 63. Global Cannabinoid Derived Pharmaceutical Sales Market Share by Application (2026-2031)
Table 64. Global Cannabinoid Derived Pharmaceutical Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Cannabinoid Derived Pharmaceutical Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Cannabinoid Derived Pharmaceutical Revenue Market Share by Application (2020-2025)
Table 67. Global Cannabinoid Derived Pharmaceutical Revenue Market Share by Application (2026-2031)
Table 68. Global Cannabinoid Derived Pharmaceutical Price (US$/Unit) by Application (2020-2025)
Table 69. Global Cannabinoid Derived Pharmaceutical Price (US$/Unit) by Application (2026-2031)
Table 70. Cara Therapeutics Inc Company Information
Table 71. Cara Therapeutics Inc Description and Business Overview
Table 72. Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Product
Table 74. Cara Therapeutics Inc Recent Developments/Updates
Table 75. Arena Pharmaceuticals Company Information
Table 76. Arena Pharmaceuticals Description and Business Overview
Table 77. Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Product
Table 79. Arena Pharmaceuticals Recent Developments/Updates
Table 80. Cannabics Pharmaceuticals Inc Company Information
Table 81. Cannabics Pharmaceuticals Inc Description and Business Overview
Table 82. Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Product
Table 84. Cannabics Pharmaceuticals Inc Recent Developments/Updates
Table 85. Echo Pharmaceuticals Company Information
Table 86. Echo Pharmaceuticals Description and Business Overview
Table 87. Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Product
Table 89. Echo Pharmaceuticals Recent Developments/Updates
Table 90. Gw Pharmaceuticals Company Information
Table 91. Gw Pharmaceuticals Description and Business Overview
Table 92. Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Product
Table 94. Gw Pharmaceuticals Recent Developments/Updates
Table 95. Inmed Pharmaceuticals Company Information
Table 96. Inmed Pharmaceuticals Description and Business Overview
Table 97. Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Product
Table 99. Inmed Pharmaceuticals Recent Developments/Updates
Table 100. Insys Therapeutics Inc Company Information
Table 101. Insys Therapeutics Inc Description and Business Overview
Table 102. Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Product
Table 104. Insys Therapeutics Inc Recent Developments/Updates
Table 105. Larapharm Company Information
Table 106. Larapharm Description and Business Overview
Table 107. Larapharm Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Larapharm Cannabinoid Derived Pharmaceutical Product
Table 109. Larapharm Recent Developments/Updates
Table 110. Mgc Pharmaceuticals Ltd Company Information
Table 111. Mgc Pharmaceuticals Ltd Description and Business Overview
Table 112. Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Product
Table 114. Mgc Pharmaceuticals Ltd Recent Developments/Updates
Table 115. One World Cannabis Company Information
Table 116. One World Cannabis Description and Business Overview
Table 117. One World Cannabis Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. One World Cannabis Cannabinoid Derived Pharmaceutical Product
Table 119. One World Cannabis Recent Developments/Updates
Table 120. Orpheus Medica Company Information
Table 121. Orpheus Medica Description and Business Overview
Table 122. Orpheus Medica Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Orpheus Medica Cannabinoid Derived Pharmaceutical Product
Table 124. Orpheus Medica Recent Developments/Updates
Table 125. Receptor Life Sciences Company Information
Table 126. Receptor Life Sciences Description and Business Overview
Table 127. Receptor Life Sciences Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Receptor Life Sciences Cannabinoid Derived Pharmaceutical Product
Table 129. Receptor Life Sciences Recent Developments/Updates
Table 130. Respirerx Pharmaceuticals Company Information
Table 131. Respirerx Pharmaceuticals Description and Business Overview
Table 132. Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Product
Table 134. Respirerx Pharmaceuticals Recent Developments/Updates
Table 135. Tetra Bio-Pharma Company Information
Table 136. Tetra Bio-Pharma Description and Business Overview
Table 137. Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Product
Table 139. Tetra Bio-Pharma Recent Developments/Updates
Table 140. Cardiol Therapeutics Company Information
Table 141. Cardiol Therapeutics Description and Business Overview
Table 142. Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Product
Table 144. Cardiol Therapeutics Recent Developments/Updates
Table 145. United Cannabis Corporation Company Information
Table 146. United Cannabis Corporation Description and Business Overview
Table 147. United Cannabis Corporation Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. United Cannabis Corporation Cannabinoid Derived Pharmaceutical Product
Table 149. United Cannabis Corporation Recent Developments/Updates
Table 150. Zynerba Pharmaceuticals Company Information
Table 151. Zynerba Pharmaceuticals Description and Business Overview
Table 152. Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Product
Table 154. Zynerba Pharmaceuticals Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Cannabinoid Derived Pharmaceutical Distributors List
Table 158. Cannabinoid Derived Pharmaceutical Customers List
Table 159. Cannabinoid Derived Pharmaceutical Market Trends
Table 160. Cannabinoid Derived Pharmaceutical Market Drivers
Table 161. Cannabinoid Derived Pharmaceutical Market Challenges
Table 162. Cannabinoid Derived Pharmaceutical Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Cannabinoid Derived Pharmaceutical
Figure 2. Global Cannabinoid Derived Pharmaceutical Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cannabinoid Derived Pharmaceutical Market Share by Type: 2024 & 2031
Figure 4. Cannabinoid Receptor Type 1 (CB1) Product Picture
Figure 5. Cannabinoid Receptor Type 2 (CB2) Product Picture
Figure 6. Others Product Picture
Figure 7. Global Cannabinoid Derived Pharmaceutical Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Cannabinoid Derived Pharmaceutical Market Share by Application: 2024 & 2031
Figure 9. Epilepsy
Figure 10. Migraine
Figure 11. Multiple Sclerosis
Figure 12. Others
Figure 13. Global Cannabinoid Derived Pharmaceutical Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Cannabinoid Derived Pharmaceutical Market Size (2020-2031) & (US$ Million)
Figure 15. Global Cannabinoid Derived Pharmaceutical Sales (2020-2031) & (K Units)
Figure 16. Global Cannabinoid Derived Pharmaceutical Average Price (US$/Unit) & (2020-2031)
Figure 17. Cannabinoid Derived Pharmaceutical Report Years Considered
Figure 18. Cannabinoid Derived Pharmaceutical Sales Share by Manufacturers in 2024
Figure 19. Global Cannabinoid Derived Pharmaceutical Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Cannabinoid Derived Pharmaceutical Players: Market Share by Revenue in Cannabinoid Derived Pharmaceutical in 2024
Figure 21. Cannabinoid Derived Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Cannabinoid Derived Pharmaceutical Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Cannabinoid Derived Pharmaceutical Sales Market Share by Country (2020-2031)
Figure 24. North America Cannabinoid Derived Pharmaceutical Revenue Market Share by Country (2020-2031)
Figure 25. United States Cannabinoid Derived Pharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Cannabinoid Derived Pharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Cannabinoid Derived Pharmaceutical Sales Market Share by Country (2020-2031)
Figure 28. Europe Cannabinoid Derived Pharmaceutical Revenue Market Share by Country (2020-2031)
Figure 29. Germany Cannabinoid Derived Pharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Cannabinoid Derived Pharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Cannabinoid Derived Pharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Cannabinoid Derived Pharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Cannabinoid Derived Pharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Cannabinoid Derived Pharmaceutical Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Cannabinoid Derived Pharmaceutical Revenue Market Share by Region (2020-2031)
Figure 36. China Cannabinoid Derived Pharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Cannabinoid Derived Pharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Cannabinoid Derived Pharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Cannabinoid Derived Pharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Cannabinoid Derived Pharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Cannabinoid Derived Pharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Cannabinoid Derived Pharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Cannabinoid Derived Pharmaceutical Sales Market Share by Country (2020-2031)
Figure 44. Latin America Cannabinoid Derived Pharmaceutical Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Cannabinoid Derived Pharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Cannabinoid Derived Pharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Cannabinoid Derived Pharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Cannabinoid Derived Pharmaceutical Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Cannabinoid Derived Pharmaceutical Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Cannabinoid Derived Pharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Cannabinoid Derived Pharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Cannabinoid Derived Pharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Cannabinoid Derived Pharmaceutical by Type (2020-2031)
Figure 54. Global Revenue Market Share of Cannabinoid Derived Pharmaceutical by Type (2020-2031)
Figure 55. Global Cannabinoid Derived Pharmaceutical Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Cannabinoid Derived Pharmaceutical by Application (2020-2031)
Figure 57. Global Revenue Market Share of Cannabinoid Derived Pharmaceutical by Application (2020-2031)
Figure 58. Global Cannabinoid Derived Pharmaceutical Price (US$/Unit) by Application (2020-2031)
Figure 59. Cannabinoid Derived Pharmaceutical Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
